Cargando…
Proteome analysis of the macroscopically affected colonic mucosa of Crohn’s disease and intestinal tuberculosis
Differentiation between intestinal tuberculosis (ITB) and Crohn’s disease (CD) is challenging in geographical regions where both these diseases are prevalent. There is a need of biomarkers for differentiation between these two disorders. Colonic biopsies from inflamed mucosa of treatment-naive patie...
Autores principales: | Rukmangadachar, Lokesh A., Makharia, Govind K., Mishra, Asha, Das, Prasenjit, Hariprasad, Gururao, Srinivasan, Alagiri, Gupta, Siddhartha Datta, Ahuja, Vineet, Acharya, Subrat K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796817/ https://www.ncbi.nlm.nih.gov/pubmed/26988818 http://dx.doi.org/10.1038/srep23162 |
Ejemplares similares
-
Two-dimensional difference gel electrophoresis (DIGE) analysis of sera from visceral leishmaniasis patients
por: Rukmangadachar, Lokesh A, et al.
Publicado: (2011) -
Differentiating Crohn’s disease from intestinal tuberculosis
por: Kedia, Saurabh, et al.
Publicado: (2019) -
CD4(+) CD25(+) FOXP3(+) T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn’s disease
por: Tiwari, Veena, et al.
Publicado: (2018) -
Genome-wide gene expression analysis for target genes to differentiate patients with intestinal tuberculosis and Crohn’s disease and discriminative value of FOXP3 mRNA expression
por: Ahuja, Vineet, et al.
Publicado: (2016) -
First Degree Relatives of Patients with Celiac Disease Harbour an Intestinal Transcriptomic Signature that Might Protect them from Enterocyte Damage
por: Acharya, Pragyan, et al.
Publicado: (2018)